CCR2 and COVID-19: Sharif-Zak et al. (2022) and Ranjbar et al. (2022) explored the role of immune markers like CCR2 in COVID-19 severity and recovery, showing that dysregulated immune responses can contribute to prolonged pulmonary issues [18,19].